{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-036607","form_type":"8-K/A","ticker":"CYPH","cik":"0001509745","company_name":"CYPHERPUNK TECHNOLOGIES INC.","filed_at":"2023-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.320568+00:00","generated_at":"2026-06-17T16:32:40.435420+00:00","sec_items":["2.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Leap Therapeutics removes requirement to file Flame Biosciences financials","bullets":["Amendment to 8-K (filed Jan 23, 2023) deletes references to filing financial statements and pro forma info for Flame Biosciences acquisition.","Company determined financial statements for the January 2023 acquisition are not required under Item 9.01 of Form 8-K.","No change to acquisition terms or closing date; procedural update only."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-036607","json":"https://secwatch.observer/filing/0001104659-23-036607.json","markdown":"https://secwatch.observer/filing/0001104659-23-036607.md","text":"https://secwatch.observer/filing/0001104659-23-036607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/0001104659-23-036607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/tm2310372d2_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:32:40.435420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"737a4c4a8057e0c2ea0a80eb651147446a9da052","claim":"CYPHERPUNK TECHNOLOGIES INC. completed an acquisition involving Flame Biosciences, Inc. (closed 2023-01-23).","evidence_excerpt":"On January 23, 2023, Leap Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing the Company’s acquisition of Flame Biosciences, Inc., a Delaware corporation, pursuant to an Agreement and Plan of Merger, dated January 17, 2023 (the “Acquisition”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923036607/0001104659-23-036607-index.htm","confidence":0.7,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Flame Biosciences, Inc."},{"label":"Closing","value":"2023-01-23"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}